Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Fabrinet (FN) - free report >>
Entera Bio Ltd. (ENTX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fabrinet (FN) - free report >>
Entera Bio Ltd. (ENTX) - free report >>
Image: Bigstock
New Strong Buy Stocks for November 16th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Entera Bio (ENTX - Free Report) : This clinical-stage biopharmaceutical company which focuses on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need, has seen the Zacks Consensus Estimate for its current year earnings increasing 20.3% over the last 60 days.
Entera Bio Ltd. Price and Consensus
Entera Bio Ltd. price-consensus-chart | Entera Bio Ltd. Quote
Neuronetics (STIM - Free Report) : This commercial-stage medical device company which focuses on design, development, and marketing products for patients who suffer from psychiatric disorders, has seen the Zacks Consensus Estimate for its current year earnings increasing 9.0% over the last 60 days.
Neuronetics, Inc. Price and Consensus
Neuronetics, Inc. price-consensus-chart | Neuronetics, Inc. Quote
Fabrinet (FN - Free Report) : This company that provides precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers and sensors,has seen the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 day.
Fabrinet Price and Consensus
Fabrinet price-consensus-chart | Fabrinet Quote
Angion Biomedica : This late-stage biopharmaceutical company which focuses on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Angion Biomedica Corp. Price and Consensus
Angion Biomedica Corp. price-consensus-chart | Angion Biomedica Corp. Quote
Futu Holdings (FUTU - Free Report) : This technology company which offers a digitized brokerage platform, has seen the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.
Futu Holdings Limited Sponsored ADR Price and Consensus
Futu Holdings Limited Sponsored ADR price-consensus-chart | Futu Holdings Limited Sponsored ADR Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.